Hepatitis B cure: From discovery to regulatory approval.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2017.05.008
Abstract: The majority of persons currently treated for chronic hepatitis B require long-term or lifelong therapy. New inhibitors of hepatitis B virus entry, replication, assembly, or secretion and immune modulatory therapies are in development. The introduction… read more here.
Keywords: regulatory approval; hepatitis; cure; discovery regulatory ... See more keywords